Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Ute Gravemann"'
Autor:
Jody Hobson‐Peters, Alberto A. Amarilla, Lina Rustanti, Denese C. Marks, Eileen Roulis, Alexander A. Khromykh, Naphak Modhiran, Daniel Watterson, Stefan Reichenberg, Frank Tolksdorf, Chryslain Sumian, Axel Seltsam, Ute Gravemann, Helen M. Faddy
Publikováno v:
Transfusion. 63:288-293
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is unlikely to be a major transfusion-transmitted pathogen, however, convalescent plasma is a treatment option used in some regions. The risk of transfusion-transmitted infections can be mi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f9e852edb2f7aee8d215a0d9dae210f
https://doi.org/10.1111/trf.17238
https://doi.org/10.1111/trf.17238
Autor:
Ute Gravemann, Michael Engelmann, Volker Kinast, Thomas Burkard, Patrick Behrendt, Torsten J. Schulze, Daniel Todt, Eike Steinmann
Publikováno v:
Transfusion. 62:2200-2204
Photodynamic treatment with methylene blue (MB) and visible light is a well-established pathogen inactivation system for human plasma. This technique is routinely used in different countries. MB/light treatment was shown to inactivate several transfu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4342f0eca3ed9c8c6966c2aa1001635e
https://doi.org/10.1111/trf.17108
https://doi.org/10.1111/trf.17108
Autor:
Wiebke Handke, Ute Gravemann, Thomas H. Müller, Franz F. Wagner, Torsten J. Schulze, Axel Seltsam
Publikováno v:
Transfusion. 62:2314-2323
Pathogen inactivation (PI) technologies for platelet concentrates and plasma are steadily becoming more established, but new PI treatment options for red blood cells (RBCs), the most commonly used blood component, still need to be developed. We prese
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9bc26bf555d63894325e3be9b27893f
https://doi.org/10.1111/trf.17098
https://doi.org/10.1111/trf.17098
Autor:
Dirk, de Korte, Ido J, Bontekoe, Áine, Fitzpatrick, Denese, Marks, Ben, Wood, Ute, Gravemann, Miloš, Bohoněk, Jose M, Kutner
Publikováno v:
Vox sanguinis, 117(5), 671-677. Wiley-Blackwell
Background and Objectives: In many countries, whole blood (WB) donations with collection times between 12 and 15 min are not allowed to be used for platelet concentrates (PC). Since the development of guidelines, many process-related changes have bee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff4f5fd667998634339d45a1271f725e
https://doi.org/10.1111/vox.13245
https://doi.org/10.1111/vox.13245
Publikováno v:
Transfusion. 60:1821-1827
Background UVC illumination of agitated platelet concentrates (PCs) inactivates pathogens and white blood cells by modifications of their nucleic acids. Related effects on mitochondrial DNA (mtDNA) in platelets serve as a basis for an efficient monit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d0cb08be8e72e412a50041c25a9f77c
https://doi.org/10.1111/trf.15904
https://doi.org/10.1111/trf.15904
Autor:
Axel Seltsam, Frank Tolksdorf, Markus Eickmann, Thomas Müller, Wiebke Handke, Ute Gravemann, Stefan Reichenberg
Publikováno v:
Vox Sanguinis
Background Emerging viruses like severe acute respiratory syndrome coronavirus (SARS-CoV), Crimean-Congo haemorrhagic fever virus (CCHFV) and Nipah virus (NiV) have been identified to pose a potential threat to transfusion safety. In this study, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe70c5d9aa2744924b146c8277c4e292
https://doi.org/10.1111/vox.12888
https://doi.org/10.1111/vox.12888
Publikováno v:
Annals of Blood. 7:28-28
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95d8d59d948ee0cd57cee314cb30150c
https://doi.org/10.21037/aob-21-44
https://doi.org/10.21037/aob-21-44
Publikováno v:
Transfusion. 59:1324-1332
Background The THERAFLEX UV-Platelets system (Maco Pharma) uses ultraviolet C (UVC) light for pathogen inactivation (PI) of platelet concentrates (PCs) without any additional photoactive compound. The aim of the study was to systematically investigat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73d2f22a0228c660120c169f6395bc0a
https://doi.org/10.1111/trf.15119
https://doi.org/10.1111/trf.15119
Autor:
Denese C. Marks, Chryslain Sumian, Agathe M. G. Colmant, Paul R. Young, Stefan Reichenberg, Helen Z. M. Faddy, Frank Tolksdorf, Jody Hobson-Peters, Axel Seltsam, Lina Rustanti, Ute Gravemann, Roy A. Hall
Publikováno v:
TransfusionREFERENCES. 60(11)
Background: Japanese encephalitis virus (JEV) is endemic to tropical areas in Asia and the Western Pacific. It can cause fatal encephalitis, although most infected individuals are asymptomatic. JEV is mainly transmitted to humans through the bite of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0d4a5ac04ccf74390ba570c05da59d3
https://pubmed.ncbi.nlm.nih.gov/32830340
https://pubmed.ncbi.nlm.nih.gov/32830340
Autor:
Martina Friesland, Ute Gravemann, Thomas Müller, Wiebke Handke, Daniel Todt, Patrick Behrendt, Axel Seltsam, Dimas F. Praditya, Eike Steinmann
Publikováno v:
Vox sanguinisReferences. 115(7)
Background and objectives As previous investigations have shown, THERAFLEX UV-Platelets, a UVC-based pathogen inactivation (PI) system, is effective against non-enveloped transfusion-relevant viruses such as hepatitis A virus (HAV), which are insensi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9296dae9a7862c437bead5d453d4184
https://pubmed.ncbi.nlm.nih.gov/32383163
https://pubmed.ncbi.nlm.nih.gov/32383163